Introduction to 3D Mammography

Collaboration Between Institutions

The Ottawa Hospital Breast Health Centre and Ottawa Integrative Cancer Centre (OICC) are collaborating on an innovative mammography technique known as 3D mammography. This advancement aims to transform current imaging methods for breast health.

Launch of the TMIST Study

These institutions have initiated the Ottawa site for the Lead-In to the Tomosynthesis Mammographic Imaging Screening Trial (TMIST). This trial evaluates the effectiveness of tomosynthesis, a digital approach that utilizes x-rays to create three-dimensional images of breast tissue. Although this technique has received approval from the U.S. FDA, it has not yet become the standard practice in clinical settings.

Advantages of Tomosynthesis

Enhanced Imaging Experience

Unlike traditional mammography, which produces two-dimensional images, tomosynthesis offers three-dimensional images. One of the key advantages of this new technique is that it does not require excessive compression of breast tissue between the mammography device’s glass plates. This reduction in compression alleviates discomfort during the procedure.

Minimizing Overlapping Tissue

Additionally, tomosynthesis helps prevent breast tissue overlaps that can obscure cancer detection. This is a significant improvement over conventional 2D mammography, which sometimes fails to identify breast cancer due to overlapping tissues.

Significance of the TMIST Study

Evaluating Effectiveness

TMIST represents the first large-scale randomized, multi-center study aimed at assessing the effectiveness of combining tomosynthesis with 2D digital mammography. The study seeks to determine if this combination can reduce the incidence of advanced breast cancers when compared to conventional 2D mammography alone.

Reducing False Positives

Previous research has indicated that this advanced technique is effective in identifying more cases of breast cancer and lowering the occurrence of false positive results. In fact, over 90% of instances where abnormalities are detected via standard 2D mammography turn out to be either normal findings or benign lesions. The high rate of false positives can lead to significant anxiety for women and may discourage them from participating in regular screening.

Future Implications of 3D Mammography

Potential Benefits

If 3D mammography demonstrates effectiveness in the TMIST trial, it could enhance diagnostic efficacy, alleviate patient anxiety, and ultimately reduce healthcare costs.

Study Recruitment

The current Lead-In study aims to recruit a total of 6,300 women across Canada, with 2,000 participants expected from Ottawa. Women attending mammographic screenings at the Breast Health Centre may be invited to take part in this significant research.

Expert Insights

Dr. Jean Seely’s Perspective

Dr. Jean Seely, who serves as the Head of Breast Imaging at the Breast Health Centre, is also an associate professor at the University of Ottawa and the lead investigator for the TMIST Lead-In in Ottawa. She emphasizes the importance of this technology, stating, “Tomosynthesis is the most advanced and exciting technology for mammography.”

Conclusion

The collaboration between the Ottawa Hospital Breast Health Centre and the Ottawa Integrative Cancer Centre marks a promising step forward in breast cancer detection with the introduction of 3D mammography. The ongoing TMIST study will provide critical insights into the effectiveness of this innovative imaging technique.